How to Buy Viking Therapeutics Stock
Viking Therapeutics Inc
Viking Therapeutics, Inc. , a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders.
Viking Therapeutics stock last closed at $28.87, up 3.33% from the previous day, and has decreased 63.72% in one year. It has overperformed other stocks in the Biotechnology industry by 0.13 percentage points. Viking Therapeutics stock is currently +52.59% from its 52-week low of $18.92, and -64.73% from its 52-week high of $81.86.
As of Apr 30, 2025, there are 112.31M VKTX shares outstanding. The market value of VKTX is $3.24B. In the last 24 hours, 5.21M VKTX shares were traded.
How to Buy Viking Therapeutics Stock
Not sure how to invest in Viking Therapeutics stock? Here's how.
- Decide where to buy Viking Therapeutics stock: You need to decide on a stock brokerage, but don't worry - we've tried dozens of online brokerages and apps to help you determine where to buy Viking Therapeutics stock.
- Create a brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've selected.
- Fund your investment account: Select your payment method and add your information.
- Evaluate Viking Therapeutics stock: The Viking Therapeutics ticker symbol is VKTX. Is Viking Therapeutics stock a good investment? Should you buy shares of VKTX? How do VKTX's underlying business fundamentals look? Do top analysts think Viking Therapeutics is a good buy? Why has VKTX's stock price moved recently? (Hint: Our stock market research website can help you decide if VKTX is a good stock to buy).
- Place your VKTX purchase: Decide if you will purchase VKTX shares at the current market price or use a limit order to buy VKTX stock at a given price.
- Get notifications regarding your investment in VKTX: Create a watchlist to watch your new investment in Viking Therapeutics stock.
Step 1: Decide where to buy Viking Therapeutics stock
You will need an online brokerage account in order to access the NASDAQ market and buy VKTX shares.
Our preferred brokerage: eToro
Based on our experience, eToro is the best stock brokerage. eToro gives you:
- Invest in stocks with zero commissions: Invest without paying trading commissions.
- Buy fractional shares: Even if you can't afford a full share, you can still invest in the stock.
- Access to global markets: From Tech to Healthcare, New York to London (for US users, only US stocks are available) — you can fill your portfolio with stocks from the world's top stock exchanges.
- Social investing: eToro offers a community with more than 20 million users worldwide. Talk to, learn from, and copy the unique crypto portfolios of top investors.
- Security: eToro is a regulated and licensed fintech leader.
- Buy other financial assets: Such as ETFs and cryptos.
Get $10 towards your purchase of stock by creating an account with eToro today. This offer is only for US users.
Open eToro AccountStep 2: Create a brokerage account
Now that you've selected the right brokerage, you need to fill out some personal details so you can buy VKTX today.
How to Open a New Brokerage Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Input your personal data to start your new trading account.
- Send your info by clicking the "Create Account" button. Get started with eToro today
Step 3: Fund your investment account
Now that you have finished signing up on one of the best stock market apps, you can securely and quickly fund your account:
Check out the walkthrough below for more details transferring money into your new investment account.
Step 4: Evaluate Viking Therapeutics stock
Once you have chosen the best place to buy Viking Therapeutics stock, it's crucial to evaluate their stock before you invest, so you truly understand the risk and opportunity.
Viking Therapeutics stock quick numbers
Fundamentals of VKTX
WallStreetZen was created to help part-time investors do more in-depth fundamental analysis.
You can view all of the due diligence checks on VKTX's stock page.
Is VKTX stock overvalued?
Analysts use many financial metrics, analyses, models, and charts to gauge VKTX's true value.
Using relative valuations methods:
- VKTX may be undervalued based on its P/B ratio of 3.83x, relative to Biotechnology industry P/B ratio of 4.45x
You can do more valuation analysis on VKTX's stock here.
How do VKTX Financials look?
Pros:
- VKTX has $851.90M in cash and short term investments. This is enough to cover its annual cash burn of $133.99M.
- VKTX has cash burn of 133987000. It has sufficient cash and short-term investments to cover this for at least one year.
- There are more short-term assets than long-term liabilities on the VKTX balance sheet.
- VKTX has a low debt to equity ratio of 0.02.
- Total VKTX debt is lower than 5 years ago, relative to shareholder equity.
- There are more short-term assets than short-term liabilities on the VKTX balance sheet.
Do Wall Street analysts think it's a good time to buy VKTX stock
Out of 10 Equities analysts who monitor VKTX, the consensus analyst rating on VKTX is a Strong Buy
It's important to note that analyst forecasts are not recommendations, nor are they financial advice.
Most Recent VKTX Analyst Forecasts
George Farmer, a top 25% analyst from ScotiaBank initiates coverage on VKTX with a buy rating and announces their VKTX price target of $102.00, on Feb 13, 2025.
David Lebovitz, a bottom 14% analyst from Citigroup initiates coverage on VKTX with a hold rating and announces their VKTX price target of $38.00, on Feb 7, 2025.
Naz Rahman, a bottom 1% analyst from Maxim Group maintains VKTX with a strong buy rating and lowers their VKTX price target from $120.00 to $70.00, on Feb 7, 2025.
Mayank Mamtani, a top 4% analyst from B. Riley Securities reiterates VKTX with a strong buy rating and lowers their VKTX price target from $109.00 to $96.00, on Feb 7, 2025.
Biren Amin, a bottom 4% analyst from Piper Sandler maintains VKTX with a strong buy rating and lowers their VKTX price target from $74.00 to $71.00, on Feb 6, 2025.
You can dive deeper into what analysts are projecting on the Viking Therapeutics stock forecast page.
VKTX Technicals
What are VKTX executives and large shareholders up to?
Over the past year, executives and large shareholders at VKTX have sold more shares than they have bought.
Matthew W. Foehr, Director of VKTX, was the latest VKTX insider to buy. They bought $166,288.00 worth of VKTX shares on Apr 11, 2025.
Research more about who owns VKTX stock here.
Does VKTX stock generate passive income?
No, Viking Therapeutics doesn't provide an income stream by paying out dividends.
What do other traders have to say about VKTX?
One of the biggest reasons eToro is our top-rated brokerage is because of its social trading community.
Click below to find out what other investors have to say.
Step 5: Place your VKTX purchase
There are two main order types:
- Market order: A market order is an order to buy or sell a stock at the best possible price.
Market orders are mostly the best for newer investors. - Limit order: A limit order enables you to buy or sell a stock at a specific price (or better).
If you want to ensure you're buying or selling at a specific dollar amount, place a limit order.
Hit the Open button and your broker will execute the order.
If you require additional assistance buying stocks on eToro, click the how to video below:
Step 6: Get notifications regarding your investment in VKTX
Now that you own some shares in VKTX, you'll want to stay up-to-date on your new company.
Make a watchlist to keep tabs on your VKTX stock.
VKTX Feed
How to Buy Stock in Viking Therapeutics
To reiterate, here are the 6 steps you need to take to buy Viking Therapeutics stock right now:
- Decide where to buy Viking Therapeutics stock
- Create a brokerage account
- Fund your investment account
- Evaluate Viking Therapeutics stock
- Place your VKTX purchase
- Get notifications regarding your investment in VKTX
If you need a online brokerage, eToro is our recommended option.
Get Started with eToro TodayIf you would like to watch your investment in Viking Therapeutics, create a watchlist today.
Other Articles You May Find Useful
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.